Advancing Cancer Care for Dogs
We are transforming canine cancer care through ongoing scientific research and innovation in therapeutic treatments.
Peer Reviewed by Nature™: Remarkable Survival Gains for Canine Cancer Patients. See how we work with:
New approaches to the development of cancer therapeutics are urgently needed to improve the current 89% failure rate of novel drugs in clinical trials, and to improve patient outcomes. Spontaneous cancer in companion animals represents a unique opportunity for investigation of novel therapeutics for human and veterinary use
Despite a growing number of targeted cancer treatments in development each year, few are able to reach cancer patients due to the rate at which evidence is generated from human clinical trials
Dog cancer research advances pursuit of drugs for humans and canines
Published June 19, 2023 | Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans
Could Fido lead us to better cancer drugs?
Despite a growing number of targeted cancer treatments in development each year, few are able to reach cancer patients due to the rate at which evidence is generated from human clinical trials
World’s largest genomic study of canine cancer reveals potential for novel human cancer treatments
Researchers from Stanford AI Health and One Health, the world’s first translational canine cancer care company, published the results from the largest-ever genomic study of canine cancer which revealed a promising path for enhanced human cancer treatments.
There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.
Precision medicine can offer a hopeful prognosis. FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible. Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.
Forrest was diagnosed with splenic cancer and given one month to live.
Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.
Forrest, Golden Retriever
Hemophagocytic Histiocytic Sarcoma
Trusted by the Leading Veterinary Oncologists
Thousands of dogs have benefitted from FidoCure® when other options were limited.
Toulouse
“Since starting treatment, Toulouse’s tumors have regressed. FidoCure® brought us hope for Toulouse when we thought we didn’t have any options left.” — Daniel, FL
Lizzie
“Thanks to FidoCure®, Lizzie is 100% active again, eating well, and in remission for 5 months.” — Kimberley and Francois, CT
Gracie
“[Our vet] told us about the One Health Company’s precision medicine solution, FidoCure®… Now, exactly two months later, Gracie’s cancer is in remission.” — The Gonzalez Family, FL
Resources & Education
-
What to Know About Anal Sac Carcinoma
by FidoCure
Anal sac carcinoma is a highly aggressive cancer that develops in the small glandular structures on either side of a dog's anus. These sacs […]
-
FidoCure Leads Canine Cancer Research with the World’s Largest Canine Cancer Database
by FidoCure
At FidoCure, we're committed to transforming cancer care for dogs through precision medicine. Our journey began with a mission to address a […]
-
FidoCure Celebrates National Veterinary Technician Week
by Christina K. Lopes
As National Veterinary Technician Week (October 13-19) approaches, FidoCure is proud to celebrate the vital role vet techs play in […]
-
A Guide to Soft Tissue Sarcoma in Dogs
by FidoCure
Soft tissue sarcomas are one of the most common cancers affecting our canine companions. These tumors develop from a variety of soft tissue […]
-
Do Human Cancer Drugs Work on Dogs With Cancer?
by FidoCure
At FidoCure, we're pioneering a revolutionary approach to treating canine cancer by bringing the power of precision medicine from human […]
-
Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer
by FidoCure
Hepatocellular carcinoma (HCC) is the most common primary liver cancer in dogs. It can present as a single mass, multiple nodules, or […]
